[Treatment of Paget's disease of bone with salmon calcitonin (author's transl)]. 1981

F Kuhlencordt, and J D Ringe, and H P Kruse

Subcutaneous injections for two days of 100 MRC units each of synthetic salmon calcitonin were administered to 40 out of 77 patients with Paget's disease of bone. Chemical pathology (alkaline serum phosphatase, hydroxyprolinuria) showed an initially satisfactory response of all patients to this treatment. Resistance developed in 6 out of 8 patients on long term treatment with recurrence of increased serum alkaline phosphatase, occurring after 4 months at the earliest and 24 months at the latest. Human calcitonin may be an alternative of treatment in these cases of secondary resistance. Treatment with calcitonin is nearly risk-free and represents a definite progress in comparison with earlier forms of treatment.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010001 Osteitis Deformans A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry. Paget's Disease of Bone,Osseous Paget's Disease,Paget Disease of Bone,Paget Disease, Bone,Pagets Disease, Bone
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006909 Hydroxyproline A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation. Oxyproline,4-Hydroxyproline,cis-4-Hydroxyproline,4 Hydroxyproline,cis 4 Hydroxyproline
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.

Related Publications

F Kuhlencordt, and J D Ringe, and H P Kruse
January 1976, Acta clinica Belgica,
F Kuhlencordt, and J D Ringe, and H P Kruse
July 1978, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
F Kuhlencordt, and J D Ringe, and H P Kruse
September 1974, British medical journal,
F Kuhlencordt, and J D Ringe, and H P Kruse
January 1978, Zeitschrift fur Alternsforschung,
F Kuhlencordt, and J D Ringe, and H P Kruse
January 1977, Revue du rhumatisme et des maladies osteo-articulaires,
F Kuhlencordt, and J D Ringe, and H P Kruse
November 1977, Canadian Medical Association journal,
F Kuhlencordt, and J D Ringe, and H P Kruse
November 1988, Journal of the American Geriatrics Society,
F Kuhlencordt, and J D Ringe, and H P Kruse
August 1980, Wiener klinische Wochenschrift,
F Kuhlencordt, and J D Ringe, and H P Kruse
January 1977, Clinical orthopaedics and related research,
F Kuhlencordt, and J D Ringe, and H P Kruse
January 1982, Medicina clinica,
Copied contents to your clipboard!